Inhibition by hydroxyl radicals of calcitonin gene-related peptide- mediated neurogenic vasorelaxation in isolated canine lingual artery

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 1, 1997, Pages 492-500

  Norisue, Masahiro ^a   Todoki, Kazuo ^a   Okabe, Eiichiro ^a  

^a KANAGAWA DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CATALASE; CROMAKALIM; DEFEROXAMINE MESYLATE; DIMETHYL SULFOXIDE; DIMETHYLTHIOUREA; FERROUS GLUCONATE; GLIBENCLAMIDE; HYDROXYL RADICAL; NORADRENALIN;

ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; BLOOD VESSEL INNERVATION; CONTROLLED STUDY; DOG; ELECTRON SPIN RESONANCE; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE RELAXATION; STIMULUS RESPONSE; VASCULAR SMOOTH MUSCLE;

ANIMALS; BENZOPYRANS; CALCITONIN GENE-RELATED PEPTIDE; CROMAKALIM; CYCLIC GMP; DOGS; FEMALE; HUMANS; HYDROXYL RADICAL; MALE; POTASSIUM CHANNELS; PYRROLES; VASODILATION;

EID: 0030997303     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. AMARA, S. G., JONAS, V., ROSENFELD, M. G., DNG, E. S. AND EVANS, R. M.: Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298: 240-244, 1982.
2. ARORA, R. C. AND HESS, M. L.: Effect of reduced oxygen intermediates on sarcolemmal muscarinic receptors from canine heart. Biochem. Biophys. Res. Commun. 130: 133-140, 1985.
3. +-channels. Cell Sign. 2: 197-214, 1990.
4. BRAYDEN, J. E. AND LARGE, W. A.: Electrophysiological analysis of cholinergic vasodilation in the isolated rabbit lingual artery. J. Physiol. (Lond.) 327: 75P, 1986.
5. BRODY, M. J. AND SHAFFER, R. A.: Distribution of vasodilator nerve in the canine hind limb. Am. J. Physiol. 218: H470-H474, 1970.
6. BUCK, S. H. ANN BURKS, T. F.: The neuropharmacology of capsaicin: Review of some recent observations, Pharmacol. Rev. 38: 179-226, 1986.
7. BUETTNER, G. R.: Spin trapping: ESR parameters of spin adducts. Free Radical Biol. Med. 3: 259-303, 1987.
8. CHIBA, T., YAMAGUCHI, A., YAMATANI, T., NAKAMURA, A., MORISHITA, T., INUI, T., FUKUSE, M., NODA, T. AND FUJITA, T.: Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am. J. Physiol. 256: E331-E335, 1989.
9. CURTIS, W. E., MULDROW, M. E., PARKER, N. B., BARKLEY, R., LINAS, S. L. AND REPINE, J. E.: N, N'-Dimethylthiourea dioxide formation from N, N'-dimethylthiourea reflects hydrogen peroxide concentrations in simple biological systems. Proc. Natl. Acad. Sci. U.S.A. 85: 3422-3425, 1988.
10. DENNIS, T., FOURNIER, A., CADIEUX, A., POMERLEAU, F., JOLICOEUR, F. B., PIERRE, S. S. AND QUIRION, R.: hCGRPS-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J. Pharmacol. Exp. Ther. 254: 123-128, 1990.
11. DENNIS, T., FOURNIER, A., PIERRE, S. S. AND QUIRION, R.: Structure activity profile of calcitonin gene-related peptide in periopheral and brain tissues: evidence for receptor multiplicity. J. Pharmacol. Exp. Ther. 251: 718-725, 1989.
12. ECCLES, R. AND WILSON, H.: The autonomic innervation of the nasal blood vessels of the cat, J. Physiol. (Lond.) 238: 549-560, 1974.
13. FEHER, J., CSOMOS, G. AND VERECKEI, A.: Free Radical Reactions in Medicine, pp.48-147, Springer-Verlag, Heidelberg, Germany, 1987.
14. FLIGIEL, S. E. G., LEE, E. C., MCCOY, J. P., JOHNSON, K. J. AND VARANI, J.: Protein degradation following treatment with hydrogen peroxide. Am. J. Pathol. 115: 418-425, 1984.
15. FREI, B.: Natural Antioxidants in Human Health and Disease, Academic Press, Boston, 1994.
16. + channel from rabbit aorta: Modulation by cromakalim. Eur. J. Pharmacol. 167: 201-210, 1989.
17. + channels by pinacidil, cromakalim, and glibenclamide. Am. J. Physiol. 264: C1119-C1127, 1993.
18. GOODMAN, E. C. AND IVERSON, L. L.: Calcitonin gene-related peptide: Novel neuropeptide. Life Sci. 38: 2169-2178, 1986.
19. GREENBERG, S. AND PALMER, C.: Biochemical basis of analgesia: Metabolism, storage, regulation and action. Dent. Clin. North Am. 22: 31-46, 1978.
20. HAMILTON, T. C. AND WESTON, A. H.: Cromakalim, nicorandil and pinacidil: Novel drugs which open potassium channels in smooth muscle. Gen. Pharmacol. 20: 1-9, 1989.
21. IGNARRO, L. J.: Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30: 535-560, 1990.
22. ISHIBASHI, T., LEE, C. AND OKABE, E.: Skeletal sarcoplasmic reticulum dysfunction induced by reactive oxygen intermediates derived from photoactivated rose bengal. J. Pharmacol. Exp. Ther. 277: 350-358, 1996.
23. KATZ, A. M. AND MESSINEO, F. C.: Lipid-membrane interactions and the patho-genesis of ischemic damage in the myocardium. Circ. Res. 48: 1-16, 1981.
24. KOBAYASHI, D., TODOKI, K., OZONO, S. AND OKABE, E.: Calcitonin gene-related peptide mediated neurogenic vasorelaxation in the isolated canine lingual artery. Jpn. J. Pharmacol. 67: 329-339, 1995.
25. KONTOS, H. A.: Oxygen radicals in cerebral vascular injury. Circ. Res 57-508-516, 1985.
26. KUBOTA, M., MOSELEY, J. M., BUTERA, L., DUSTING, G. J., MACDONALD, P. S. AND MARTIN, T. J.: Calcitonin gene-related peptide stimulates cyclic AMP formation in rat aortic smooth muscle cells. Biochem. Biophys. Res. Commun 132-88-94, 1985.
27. LAMB, F. S. AND WEBB, R. C.: Vascular effects of free radicals generated by electrical stimulation. Am. J. Physiol. 247: H709-H714, 1984.
28. LANGTON, P. D., NELSON, M. T., HUANG, Y. AND STANDEN, N. B.: Block of calcium-activated potassium channels in mammalian arterial myocytes by tetraethylammonium ions. Am. J. Physiol. 260: H927-H934, 1991.
29. 2+-ATPase activity of masseter muscle sarcoplasmic reticulum. Jpn. J. Pharmacol. 67: 21-28, 1995.
30. LUNDBERG, J. M.: Evidence for the existence of vasoactive intestinal polypeptide (VIP) and acetylcholine neurons in cat exocrine glands. Morphological, anatomical and functional studies. Acta Physiol. Scand. Suppl. 496: 1-57, 1981.
31. LUNDBERG, J. M., ANGGARD, A. AND FAHRENKRUG, J.: VIP as a mediator of hexamethonium-sensitive, atropine-resistant vasodilation in the cat tongue. Acta Physiol. Scand. 116: 387-392, 1982.
32. MARSHALL, J. J. AND KONTOS, H. A.: Endothelium-derived relaxing factors. A perspective from in vivo data. Hypertension 16: 371-386, 1990.
33. MULDERRY, P. K., GHATEI, M. A., RODRIGO, J., ALLEN, J. M., ROSENFELD, M. G., POLAK, J. M. AND BLOOM, S. R.: Calcitonin gene-related peptide in cardiovascular tissues of the rat. Neuroscience 14: 947-954, 1985.
34. + channels. Nature 344: 770-773, 1990.
35. + channel. Life Sci. 61: 1851-1856, 1992.
36. OKABE, E., KATO Y., KOHNO, H., HESS, M. L. AND ITO, H.: Inhibition by free radical scavengers and by cyclooxygenase inhibitors of the effect of acidosis on calcium transport by masseter muscle sarcoplasmic reticulum. Biochem. Pharmacol. 34: 961-968, 1985.
37. OKABE, E., KUSE, K., SEKISHITA, T., SUYAMA, N., TANAKA, K. AND ITO, H: The effect of ryanodine on oxygen free radical-induced dysfunction of cardiac sarco-plasmic reticulum. J. Pharmacol. Exp. Ther. 256: 868-875, 1991.
38. OKABE, E., SUGIHARA, M., TANAKA, K., SASAKI, H. AND ITO, H.: Calmodulin and free oxygen radicals interaction with steady-state calcium accumulation and passive calcium permeability of cardiac sarcoplasmic reticulum, J. Pharmcol. Exp. Ther. 250: 286-292, 1989.
39. OKABE, E., TODOKI, K., ODAJIMA, C. AND ITO, H.: Free radicals-induced changes in mesenteric microvaacular dimensions in the anesthetized cat. Jpn. J. Pharmacol. 33: 1233-1239, 1983.
40. ROSENFELD, M. G., MERMOD, J. J., AMARA, S. G., SWANSON, L. W., SAWCHENKO, P. E., RIVIER, J., VALE, W. W. AND EVANS, R. M.: Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304: 129-135, 1983.
41. RUBANYI, G. M.: Vascular effects of oxygen-derived free radicals. Free Radical Biol. Med. 4: 107-120, 1988.
42. SAITO, A,. KIMURA, S. AND GOTO, K.: Calcitonin gene-related peptide as potential neurotransmitter in guinea pig right atrium. Am. J. Physiol, 250: H693-H698, 1986.
43. SAMUELSSON, B.: Prostaglandins, thromboxanes, and leukotrienes: Formation and biological roles. Harvey Lect. 75: 1-40, 1979.
44. SASAKI, H. AND OKABE, E.: Modification by hydroxyl radicals of functional reactivity in rabbit lingual artery. Jpn. J. Pharmacol. 62: 305-314, 1993.
45. + channels in arterial smooth muscle. Science 245: 177-180, 1989.
46. TODOKI, K., OKABE, E., KIYOSE, T., SEKISHITA, T. AND ITO, H.: Oxygen free radical-mediated selective endothelial dysfunction in isolated coronary artery. Am. J. Physiol. 262: H806-H812, 1992.
47. WALLING, C.: The nature of the primary oxidants in oxidations mediated by metal ions. In Oxidases and Related Redox Systems, ed. by T. E. King, H. S. Mason and M. Morrison, pp. 85-97, Pergamon Press, Oxford. 1982.
48. WEI, E. P., MOSKOWITZ, M. A., BOCCALINI, P. AND KONTOS, H. A.: Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles. Circ. Res. 70: 1313-1319, 1992.
49. WOLIN, M. S.: Activated oxygen metabolites as regulators of vascular tone. Klin. Wochenschr. 69: 1046-1049, 1991.
50. ZWEIER, J. L.: Measurement of superoxide-derived free radicals in the reperfused heart. J. Biol. Chem. 263: 1353-1357, 1988.